Tech Titans Investing Millions to Create Genetically Engineered Babies
By Tina Stevens,
CounterPunch
| 12. 11. 2025
Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically engineered (GE) babies, according to a recent Wall Street Journal (WSJ) report. AI mogul Sam Altman, cryptocurrency entrepreneur Brian Armstrong, venture capitalist Peter Theil and Reddit founder Alexis Ohanian are supplying lavish funds to explore human embryo gene editing and to market “polygenic” (i.e., multi-gene) screening of embryos for quality control.
While their brassy business models boast the goal of eliminating diseases (for which other less risky interventions are available), skeptical experts can sniff an agenda that is peddled more discretely: engineering children to “enhance” traits such as eye color, height, intelligence, and athletic ability. UC Berkeley scientist Fyodor Urnov’s critique is decisive. “These people armed with very poorly deployed sacks of cash are working on “baby improvement,” he said. University of Virginia behavioral geneticist Eric Turkheimer characterized the marketing of unproven probabilistic screening methods as “corporate eugenics.”
Even when disassociated from the eugenic savagery of WWII Nazi Germany, the tech titans’ “techno eugenics” hasten the arrival of bio-entrepreneurially created societies of...
Related Articles
By staff, Japan Times | 12.04.2025
Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over "designer babies."
A government expert panel broadly approved a proposal, including the ban...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...